2 UK stocks I’ve bought ahead of a forecast recession!

Amid some pretty negative economic forecasts, I’ve bought these two UK stocks, providing my portfolio with extra defensive cover.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young Asian man shopping in a supermarket

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

UK stocks have seen a significant upturn since Rishi Sunak came into office. But challenges remain. Analysts across the board are predicting a recession in the UK, and that’s not good news for stocks. The thing is, investors are always trying to gauge what the market will look like in six-12 months time. So some of this forecast negative pressure is already priced in.

But with forecasts worsening, I’ve recently bought more shares in defensive stocks Haleon (LSE:HLN) and Unilever (LSE:ULVR). Here’s why.

Haleon

Haleon is trading around 13% below its listing price in the summer. In fact, its market value is roughly half of what Unilever had offered to buy it for earlier in the year. One of the reasons for the dip is a legal case brought against GSK — from which it had split in the summer. However, Haleon insists the case will not impact it.

But, importantly, Haleon has defensive qualities. And this means the stock tends to outperform when times are tough. Haleon owns brands such as SensodyneAdvil, and Voltaren, all of which are household names. 

This is important because evidence suggests that customers continue to buy branded products even when finances are squeezed. And that gives Haleon pricing power and the capacity to pass on costs to consumers. However it’s definitely worth noting that a deep recession naturally won’t be good for any customer-facing businesses.

Despite the challenge environment, the firm has performed well so far this year. It saw operating profits grow more than 20% in the six months ended 30 June, driven by increased profits and margins. Haleon has kept its full-year guidance for organic revenue growth at 6-8%.

It’s not cheap, with a price-to-earnings (P/E) ratio around 17. But that also reflects the strength of the company’s long-term growth prospects.

Unilever

Unilever is among the best-known defensive stocks on the FTSE 100. The multinational owns many household brands such as Hellmann’s, Marmite, Heinz, Persil, and Lifebuoy (the latter soap brand only appears to be sold in developing nations).

Like Haleon, it doesn’t come cheap right now. Investors have been hunting defensive stocks, but the consumer goods giant also has considerable growth potential. As such, Unilever trades with a P/E ratio of 17.5.

Its defensive qualities have already been demonstrated this year. In the third quarter, it hiked prices by 12.5%, but only saw volumes declining 1.6%. As such, underlying sales growth accelerated to 10.6% in Q3 while turnover increased 17.8%, including a currency impact of 8.8%.

Unilever is one of several UK stocks to have benefitted from the weakness of the pound. The firm sells in 190 countries and around 17% of its revenue comes from the US, leading to inflated GBP revenues.

However, one thing that concerns me, and other investors, is the company’s emphasis on ‘doing good’. It’s great to see a multinational using its reputation for good use, but investors, including Terry Smith, the CEO of Fundsmith, claims its coming at the expense of a strong performance.

James Fox has positions in Haleon plc and Unilever. The Motley Fool UK has recommended Haleon plc and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

What on earth’s going to happen to the BP share price in 2026?

Harvey Jones looks at how the BP share price is shaping up for the year ahead, and finds investors have…

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

Have a £20,000 lump sum? Here’s how to target a £8,667 yearly passive income

How to turn £20,000 into a £8,667 passive income? Our Foolish author explains one counterintuitive strategy to build such an…

Read more »

British coins and bank notes scattered on a surface
Dividend Shares

2 dividend stocks that yield double the current UK interest rate

Following the latest UK interest rate cut, Jon Smith points out a couple of options that offer generous income relative…

Read more »

Investing Articles

A 9% yield and now this! Check out the stunning Taylor Wimpey share price forecast for 2026

Harvey Jones has kept the faith in Taylor Wimpey shares despite a difficult run, bolstered by their incredible yield. Next…

Read more »

Investing Articles

How much do you need in an ISA to aim for a life-changing passive income of £30,000 a year?

Harvey Jones says ISA savers can transform their futures in 2026 by investing in FTSE 100 dividend stocks with huge…

Read more »

Investing Articles

My top 10 ISA and SIPP stocks in 2026

Find out why a FTSE 100 investment trust is now this writer's top holding across his Stocks and Shares ISA…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

£10,000 invested in Rolls-Royce shares 5 Christmases ago is now worth…

James Beard reflects on the post-pandemic Rolls-Royce share price rally and whether the group could become the UK’s most valuable…

Read more »

Investing Articles

Will Nvidia shares continue their epic run into 2026 and beyond?

Nvidia shares have an aura of invincibility as an AI boom continues to benefit the chipmaker. Can anything stop the…

Read more »